Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nuclear Medicine and Biology is Scopus-indexed (Q2, CiteScore 5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0969-8051Verify ISSN ↗1872-9614Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,740 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 95 / 361 | 73rd | Q2 |
| Cancer Research | 127 / 233 | 45th | Q3 |
| Molecular Medicine | 105 / 179 | 41st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1986–present, best quartile Q2, CiteScore 5.
Nuclear Medicine and Biology is Q2 in Radiology, Nuclear Medicine and Imaging (rank 95 of 361), Q3 in Cancer Research (rank 127 of 233) and Q3 in Molecular Medicine (rank 105 of 179), by CiteScore 2025.
Nuclear Medicine and Biology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.748, quartile Q2, with an H-index of 103.
The publisher lists an article processing charge of about US$3,740 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Nuclear Medicine and Biology is published by Elsevier Inc. Its print ISSN is 0969-8051 and its online ISSN is 1872-9614.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nuclear Medicine and Biology has an h-index of 109 and a 2-year mean of 0.79 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q2. On 2-year citations it ranks #237 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Nuclear Medicine and Biology published 573 papers in 2025; its busiest recent year was 2022 with 614. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from United States (20.8%), Japan (15.5%) and China (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.